These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2082620)

  • 1. Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity.
    Dirckx L; Lindemann D; Ette R; Manzoni C; Moritz D; Mous J
    Virus Res; 1990 Dec; 18(1):9-20. PubMed ID: 2082620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    Grimaila RJ; Fuller BA; Rennert PD; Nelson MB; Hammarskjöld ML; Potts B; Murray M; Putney SD; Gray G
    J Virol; 1992 Apr; 66(4):1875-83. PubMed ID: 1548744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.
    Murphy CI; Lennick M; Lehar SM; Beltz GA; Young E
    Genet Anal Tech Appl; 1990 Oct; 7(6):160-71. PubMed ID: 2076345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.
    Koch M; Pancera M; Kwong PD; Kolchinsky P; Grundner C; Wang L; Hendrickson WA; Sodroski J; Wyatt R
    Virology; 2003 Sep; 313(2):387-400. PubMed ID: 12954207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1.
    Lee WR; Syu WJ; Du B; Matsuda M; Tan S; Wolf A; Essex M; Lee TH
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2213-7. PubMed ID: 1549584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4.
    Gram GJ; Hemming A; Bolmstedt A; Jansson B; Olofsson S; Akerblom L; Nielsen JO; Hansen JE
    Arch Virol; 1994; 139(3-4):253-61. PubMed ID: 7832633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.
    Platt EJ; Madani N; Kozak SL; Kabat D
    J Virol; 1997 Feb; 71(2):883-90. PubMed ID: 8995604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A; Stamatatos L
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120.
    McKeating JA; Bennett J; Zolla-Pazner S; Schutten M; Ashelford S; Brown AL; Balfe P
    J Virol; 1993 Sep; 67(9):5216-25. PubMed ID: 7688820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
    Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
    AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates.
    Devico A; Silver A; Thronton AM; Sarngadharan MG; Pal R
    Virology; 1996 Apr; 218(1):258-63. PubMed ID: 8615032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding.
    Li Y; Luo L; Rasool N; Kang CY
    J Virol; 1993 Jan; 67(1):584-8. PubMed ID: 8416385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4.
    Syu WJ; Huang JH; Essex M; Lee TH
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3695-9. PubMed ID: 2339113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N463 Glycosylation Site on V5 Loop of a Mutant gp120 Regulates the Sensitivity of HIV-1 to Neutralizing Monoclonal Antibodies VRC01/03.
    Wang W; Zirkle B; Nie J; Ma J; Gao K; Chen XS; Huang W; Kong W; Wang Y
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):270-7. PubMed ID: 25751231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.
    Jabbar MA; Nayak DP
    J Virol; 1990 Dec; 64(12):6297-304. PubMed ID: 2243395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies.
    Hemming A; Gram GJ; Bolmstedt A; Losman B; Hansen JE; Ricksten A; Olofsson S
    Arch Virol; 1996; 141(11):2139-51. PubMed ID: 8973529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.
    Willey RL; Martin MA; Peden KW
    J Virol; 1994 Feb; 68(2):1029-39. PubMed ID: 7904656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1.
    Fenouillet E; Gluckman JC; Bahraoui E
    J Virol; 1990 Jun; 64(6):2841-8. PubMed ID: 2335819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coreceptor function of mutant human CD4 molecules without affinity to gp120 of human immunodeficiency virus.
    Tachibana M; Siddiqi MA; Ikegami Y; Eshima K; Shirota-Someya Y; Tahara-Hanaoka S; Koito A; Iizuka M; Shinohara N
    J Biol Chem; 2000 Jul; 275(27):20288-94. PubMed ID: 10779509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.